Cantel Medical (NYSE:CMD) Upgraded to Buy at ValuEngine

ValuEngine upgraded shares of Cantel Medical (NYSE:CMD) from a hold rating to a buy rating in a research report sent to investors on Wednesday morning, ValuEngine reports.

CMD opened at $62.46 on Wednesday. The stock has a market cap of $2.63 billion, a price-to-earnings ratio of 25.70 and a beta of 0.96. The stock’s 50 day moving average price is $70.90 and its 200-day moving average price is $77.61. Cantel Medical has a one year low of $59.94 and a one year high of $93.87. The company has a debt-to-equity ratio of 1.26, a quick ratio of 1.36 and a current ratio of 2.45.

Cantel Medical (NYSE:CMD) last released its earnings results on Tuesday, December 10th. The company reported $0.65 EPS for the quarter, beating analysts’ consensus estimates of $0.57 by $0.08. The firm had revenue of $257.25 million for the quarter, compared to analysts’ expectations of $250.70 million. Cantel Medical had a return on equity of 14.91% and a net margin of 4.38%. As a group, analysts predict that Cantel Medical will post 2.8 earnings per share for the current fiscal year.

The company also recently disclosed a Semi-Annual dividend, which will be paid on Friday, January 31st. Investors of record on Friday, January 17th will be paid a $0.105 dividend. The ex-dividend date of this dividend is Thursday, January 16th. This is a boost from Cantel Medical’s previous Semi-Annual dividend of $0.10. Cantel Medical’s dividend payout ratio is 8.86%.

Cantel Medical Company Profile

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.

Read More: Differences Between Momentum Investing and Long Term Investing

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.